BRANMOOR
THURSDAY · 14 MAY 2026

Hydrocortisone Sodium Succinate

Injection · trading as Solu-Cortef

Resolved Resolved — 1147 days on record FDA record updated

Moderate impact — Limited manufacturing base (2 known suppliers); substitute sourcing may be constrained.

FDA shortage record

Substance
Hydrocortisone Sodium Succinate
Brand name
Solu-Cortef
Manufacturers / suppliers
  • Pharmacia & Upjohn Company LLC
  • Hospira, Inc., a Pfizer Company
2 known suppliers in current FDA data
Dosage form
Injection
Presentation
Solu-cortef, Injection, 500 mg/vial (NDC 0009-0016-12)
Route(s)
INTRAMUSCULAR, INTRAVENOUS
Therapeutic category
Pulmonary/Allergy, Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Pediatric, Renal, Rheumatology
Package NDC
0009-0016-12
Initially posted
03/24/2023
Days on shortage list
1147
Current FDA status
Resolved
Shortage entries (current dataset)
2 records for Hydrocortisone Sodium Succinate

Why this shortage matters

Oncology drugs treat cancers including solid tumors, leukemia, and lymphoma. Shortages of chemotherapy agents can delay or interrupt regimens where dose timing and intensity directly affect treatment outcomes.

FDA therapeutic class: Pulmonary/Allergy, Dermatology, Endocrinology/Metabolism, Gastroenterology, Hematology, Neurology, Oncology, Ophthalmology, Pediatric, Renal, Rheumatology

Manufacturer contact

Per the FDA record, the manufacturer's contact for supply inquiries is 844-646-4398.

If you're affected by this shortage

  • Talk to your prescribing clinician or pharmacist about therapeutic alternatives. Do not switch medications on your own.
  • Ask your pharmacy to check supply across multiple wholesalers and other branches.
  • Check current pharmacy pricing and availability via GoodRx (affiliate link).
  • Report a continuing supply problem to FDA via the FDA Drug Shortages contact form.

Sources

Important

This page reproduces publicly available FDA shortage data for informational purposes only. It is not medical advice and does not establish a clinician-patient relationship. Shortage status changes frequently; verify directly with your pharmacist or the FDA Drug Shortages site before making any treatment decision.